SHENZHEN PHARMACIN CO LTD has a total of 19 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2015. It filed its patents most often in United States, EPO (European Patent Office) and United Kingdom. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are ZHUHAI BEIHAI BIOTECH CO LTD, RELMADA THERAPEUTICS INC and PRESBYOPIA THERAPIES LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | EPO (European Patent Office) | 2 | |
#3 | United Kingdom | 2 | |
#4 | Australia | 1 | |
#5 | Brazil | 1 | |
#6 | Canada | 1 | |
#7 | Israel | 1 | |
#8 | Japan | 1 | |
#9 | Republic of Korea | 1 | |
#10 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Wang Zeren | 14 |
#2 | Xu Jun | 12 |
#3 | Qu Long | 8 |
#4 | Zhang Xiao | 5 |
#5 | Jiang Guisheng | 4 |
#6 | Wang Lijiang | 4 |
#7 | Chen Shunqin | 4 |
#8 | Zhao Yulan | 4 |
#9 | Sun Meili | 4 |
#10 | Zeren Wang | 3 |
Publication | Filing date | Title |
---|---|---|
US2020237784A1 | Pharmaceutical compositions | |
WO2020151633A1 | Pharmaceutical compositions | |
US2017281631A1 | Pharmaceutical formulation of palbociclib and a preparation method thereof | |
EP3437637A1 | Pharmaceutical preparation of palbociclib and preparation method thereof |